Security key
800677106
SANGAMO THERAPEUTICS, INC - Common Stock, par value $0.01 per share (SGMOQ)
CUSIP: 800677106
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Total 13F shares
- 62,601,923
- Total 13F value
- $42,143,656
- Share change
- -10,625,759
- Put/Call ratio
- 115%
- SEC-reported price per share
- $0.67
- Number of holders
- 112
- Value change
- -$4,085,084
- Number of buys
- 58
- Number of sells
- 34
- Shares outstanding
- 414,294,446
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
112
Top holders
10
SGMOQ full security history
Ownership snapshot
Full 13F holder table
SANGAMO THERAPEUTICS, INC SEC filings
SANGAMO THERAPEUTICS, INC company facts
Broader feeds
Ownership snapshot
Top reported holders of SGMOQ - SANGAMO THERAPEUTICS, INC - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
WASATCH ADVISORS LP
Disclosed value leader
Yorkville Advisors Global...
Comparable rows
1/15
Latest evidence
30 Jun 2025
13F
13D/G
3/4/5
Lead comparable stake: 2.1%
14 rows are not safely comparable across share classes.
13D/G row: WASATCH ADVISORS LP
Showing 1-6 of 15 holder rows.
Quick read
WASATCH ADVISORS LP leads the comparable SEC ownership view at 2.1%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens WASATCH ADVISORS LP's linked filing trail.
Comparable ownership
Top 1
WASATCH ADVISORS LP
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| WASATCH ADVISORS LP |
13F
13D/G
Company
|
2.1%
Reported 13D/G
· 30 Sep 2025
|
$4,376,096
8,084,419 shares
|
— | 30 Jun 2025 |
| BIOGEN INC. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$6,745,007
17,652,466 shares
|
— | 26 Sep 2023 |
| Yorkville Advisors Global, LP |
13F
Company
|
—
denominator unverified
|
$11,908,600
22,000,000 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$5,071,728
9,374,728 shares
|
— | 30 Jun 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$3,702,186
6,839,434 shares
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$2,602,955
4,808,708 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
112
Shares
62,601,923
Rows available
112
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
110
Q3 2025 holders
112
Holder diff
2
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|